Napabucasin: An Update on the First-in-Class Cancer Stemness Inhibitor
Crossref DOI link: https://doi.org/10.1007/s40265-017-0759-4
Published Online: 2017-06-01
Published Print: 2017-07
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Hubbard, Joleen M. http://orcid.org/0000-0001-8250-4920
Grothey, Axel
License valid from 2017-06-01